Jagsonpal Pharmaceuticals Board Recommends Dividend of Rs. 4 Per Share for FY2025-26
Jagsonpal Pharmaceuticals Limited announced that its Board of Directors, at a meeting held on April 27, 2026, recommended a dividend for the financial year ended March 31, 2026.The company confirmed that the Board recommended a dividend of Rs. 4/- per equity share. This recommendation equates to 200% of the face value of the equity share, which stands at Rs. 2/-.
The company stated that the proposed dividend shall be payable after receiving approval from the shareholders at the 47th Annual General Meeting.
Jagsonpal Pharmaceuticals noted that the record date and the tentative date of payment for the dividend will be communicated separately.
JAGSNPHARM Stock Price Movement
Today, Jagsonpal Pharmaceuticals Limited shares edged higher to close at ₹203.67, gaining 2.23% for the day. The stock saw significant investor interest in the post-market session, trading a volume of 148,205 shares.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.